Invivyd, SPEAR Study Group, VYD2311, FLINTLOCK Trial, Long COVID, Post-Vaccination Syndrome, Monoclonal Antibody, SARS-CoV-2, Phase 2 Clinical Trial,

NEW HAVEN, Conn., October 14, 2026 Invivyd, Inc. (Nasdaq: IVVD) and the SPEAR Study Group announced the initiation of...